Sale disclosed
Marion McCourt
EVP Commercial
Common Stock
- Reported value
- $1.03M
- Reported price
- $850.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
REGENERON PHARMACEUTICALS, INC.
Last 30 daysNo qualifying insider buying. No qualifying insider sales.
Showing the first 6 of 27 trades on this page.
EVP Commercial
Common Stock
EVP Commercial
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| EVP Commercial | Common StockSale10b5-1 | 1,215$850.00 / share | $1.03M | Sep 2Filed Sep 3 · 1d later | SEC filing |
| EVP Commercial | Common StockSale10b5-1 | 1,131$857.39 / share | $969.71K | Sep 3Filed Sep 3 · 0d later | SEC filing |
| Director | Common StockSale10b5-1 | 400$850.00 / share | $340K | Sep 2Filed Sep 3 · 1d later | SEC filing |
| Director | Common StockSale10b5-1 | 400$800.00 / share | $320K | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 800$800.00 / share | $640K | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Director | Common StockSale10b5-1 | 200$650.15 / share | $130.03K | Jul 2Filed Jul 7 · 5d later | SEC filing |
| Director | Common StockSale10b5-112 trades | 100avg $705.24 / share | $70.52K | May 1Filed May 4 · 3d later | 12 filings
|
| Director | Common StockSale10b5-19 trades | 100avg $777.27 / share | $77.73K | Apr 1Filed Apr 3 · 2d later | 9 filings
|
Regeneron Pharmaceuticals, Inc. - Common Stock · Stock
The filing reports a purchase for the member.
Regeneron Pharmaceuticals, Inc. - Common Stock (REGN) · Stock
The filing reports a sale for the member.
Gilbert CisnerosReporting House memberRegeneron Pharmaceuticals, Inc. - Common Stock (REGN) · Stock
The filing reports a purchase for the member.
Julia LetlowReporting House memberRegeneron Pharmaceuticals, Inc. - Common Stock (REGN) · Stock
The filing reports a purchase for the member.
Gilbert CisnerosReporting House member